{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-016922","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.514164+00:00","generated_at":"2026-06-14T04:57:41.407831+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Pieris discontinues respiratory collaboration with Genentech for scientific reasons","bullets":["Pieris and Genentech jointly ended the respiratory program in May 2023.","Program aimed at locally delivered respiratory therapies using Pieris' Anticalin technology.","Discontinuation attributed to scientific reasons; no financial terms disclosed.","Pieris furnished a June 2023 investor presentation (Exhibit 99.1) with no updated guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-016922","json":"https://secwatch.observer/filing/0001437749-23-016922.json","markdown":"https://secwatch.observer/filing/0001437749-23-016922.md","text":"https://secwatch.observer/filing/0001437749-23-016922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000143774923016922/0001437749-23-016922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000143774923016922/pirs20230601_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:57:41.407831+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}